Cervical Spondylotic Myelopathy Surgical Trial
Public ClinicalTrials.gov record NCT02076113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury and dysfunction in the US and in the world. This study aims to test the hypothesis that ventral surgery is associated with superior Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA). A secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion, and laminoplasty surgery are different. A third hypothesis is that cervical sagittal balance post-operatively is a significant predictor of SF-36 PCS outcome.
Study identification
- NCT ID
- NCT02076113
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 269 participants
Conditions and interventions
Conditions
Interventions
- Ventral (Front) decompression with Fusion Procedure
- Dorsal (Back) Decompression with Fusion Procedure
- Dorsal (back) Laminoplasty Procedure
Procedure
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2014 (Actual)
- Primary completion
- Mar 30, 2018 (Actual)
- Completion
- Dec 30, 2026 (Estimated)
- Last update posted
- Feb 20, 2026
2014 – 2026
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California- San Francisco | San Francisco | California | 94143 | — |
| Emory | Atlanta | Georgia | 30329 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Lahey Hospital and Medical Center | Burlington | Massachusetts | 01805 | — |
| Washington University School of Medicine- St. Louis | St Louis | Missouri | 63110 | — |
| Rutgers-New Jersey Medical School | Newark | New Jersey | 07103 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Columbia | New York | New York | 10032 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44106 | — |
| MetroHealth | Cleveland | Ohio | 44109 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| University of Utah Health Sciences | Salt Lake City | Utah | 84132 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02076113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02076113 live on ClinicalTrials.gov.